The pharmaceutical plant's production last year was worth 5.3 million dollars and ranks 13 th in the pharmaceutical companies ranking in Ukraine. The product portfolio includes 64 products.
As we informed yesterday the board of Directors had authorized CEO Ognyan Donev to lead negotiations and take all necessary steps towards the endorsement.
As was announced in early October, Sopahrama subscribed 108,500 shares from the capital of Latvian Olinepharma in the company's IPO.
And at the end of September Sopharma signed a contract with Polish Natur Product Zdrovit for the setting up of a joint company.
It became clear last month that Sopharma has made its first product registration on the Turkish market.
Metilprednizolon is an anti-inflammatory and anti-allergic medication that is widely used in urgent care and in cases of serious shocks or in chronic conditions, which are not affected by standard medications.
The stock rose 2.06% to an average of 8.90 leva today at a turnover of 102,519 shares.